Camereyes

CamereyesCamereyes
Camereyes

Camereyes

AI-powered diagnostic imaging for early detection of diabetic retinopathy.

2015Inactive1Tel Aviv, Israel
Rate

About

Camereyes developed an AI-powered platform for early diagnosis and management of diabetic retinopathy, a leading cause of blindness. Their technology aimed to analyze retinal images to identify early signs of the disease, enabling timely intervention and preventing vision loss.
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Camereyes do?

Camereyes developed an AI-powered platform for early diagnosis and management of diabetic retinopathy, a leading cause of blindness. Their technology aimed to analyze retinal images to identify early signs of the disease, enabling timely intervention and preventing vision loss.

How much funding has Camereyes raised?

Camereyes has raised a total of $700K in funding.

Where is Camereyes headquartered?

Camereyes is headquartered in Tel Aviv, Israel.

When was Camereyes founded?

Camereyes was founded in 2015.

What industry does Camereyes operate in?

Camereyes operates in Healthcare, Optometry, Diabetic Retinopathy, Retina, HealthTech, MedTech.

How many employees does Camereyes have?

Camereyes has approximately 1 people on record.

What is Camereyes's current status?

Camereyes's current operating status is: Inactive.

What is Camereyes's revenue?

StartupHub estimates Camereyes's annual revenue at $285K (range $154K to $513K, 63% confidence), based on comparable companies in the sector.

What is Camereyes's valuation?

StartupHub estimates Camereyes's effective valuation at $2.9M (range $1.8M to $4.2M, 10% confidence), based on comparable companies in the sector.